Ingredient

Hydrogen (benzyl)[4-[[4-[benzylethylamino]phenyl](2,4-disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)ammonium, sodium salt

⚠ EU Restricted

Identification

CAS Number 3486-30-4
EINECS / EC 222-476-0
CosIng Ref 30457
Chemical Name sodium 4-[[4-[benzyl(ethyl)amino]phenyl]-[4-[benzyl(ethyl)azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzene-1,3-disulfonate
IUPAC Name —
Formula C37H35N2NaO6S2
Mol. Weight 690.8 g/mol
InChIKey FTUYQIPAPWPHNC-UHFFFAOYSA-M

Function & Classification

EU Regulatory Status

🇪🇺
⚠ Restricted — EU Reg. 1223/2009 IV

Safety Profile

No toxicology data available yet for this ingredient.

Check SCCS opinions or CIR reports for published safety assessments.

NOAEL · Dermal Absorption % · Sensitization

Formulation Guidelines

Usage level, pH range, solubility and addition phase not yet available.

Usage Level % · Addition Phase · Solubility

Suppliers & Documents

Log in to see suppliers.

Log in or register to see suppliers and documents for Hydrogen (benzyl)[4-[[4-[benzylethylamino]phenyl](2,4-disulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)ammonium, sodium salt.

Documents

External Resources